Darin Awaya, MD
Orthopaedic Surgery · Honolulu, HINPI 1477544633
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $429,239 of the $445,121 with a category attached, or 96.4%. Hyhte Holdings Inc. accounts for 96.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $113,069, more than ten times the $9,307 reported in 2019. Among orthopaedic surgery clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $2318.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hyhte Holdings Inc.$429K
- Globus Medical$7K
- Zimmer Biomet$6K
- Amgen$2K
- Medtronic$1K
- Zimvie Inc.$378
- plus $177 from 3 others
What the payments were for
- Royalty or licence$429,23996%
- Travel & lodging$8,5522%
- Food & beverage$7,3312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hyhte Holdings Inc. | 7 | $429,239 |
| Globus Medical | 27 | $6,984 |
| Zimmer Biomet | 57 | $5,765 |
| Amgen | 50 | $1,551 |
| Medtronic(2 entities) | 40 | $1,028 |
| Zimvie Inc. | 7 | $378 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Radius Health, Inc. | 2 | $33 |
| Lemaitre Vascular, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Half Dome X$383,119
- Excelsius Robotics System$2,664
- Vitality$2,377
- Spine$1,804
- RISE-L$1,560
- Mobi-C$648
- Vital$603
- EVENITY$364
- Vital Deformity, Degen, Hooks$283
- C-TEK MAXAN$239
- OSTEOCOOL RF ABLATION$174
- 3D Printed PLIF/TLIF$154
- CREO$150
- 3D Printed IBF$142
- 3D Printed Integrated ALIF Spa$134
- Timberline$129
- KYPHON EXPRESS II KYPHOPAK TRAY$126
- IOVERA SYSTEM$125
- PrimaGen$123
- Traumaone$120
How this compares
$445,121 in reported general payments places this provider in the 95th percentile of 83 orthopaedic surgery providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 113 | $635 |
| Gabapentin | 32 | $470 |
| Celecoxib | 20 | $309 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $227 |
| Methylprednisolone | 23 | $214 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $169 |
| Meloxicam | 15 | $147 |
| Pregabalin | 18 | $116 |
| Tramadol Hcl | 27 | $90 |
| Cephalexin | 22 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Honolulu
- Cass NakasoneHonolulu$957K
- Christian KikuchiHonolulu$142K
- Paul MortonHonolulu$83K
- Gary OkamuraHonolulu$69K
- Andrew RichardsonHonolulu$55K
- Kyle MitsunagaHonolulu$52K
- Kanu OkikeHonolulu$47K
- Brian ManninoHonolulu$43K
- Morris MitsunagaHonolulu$32K
- Anthony BarciaHonolulu$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.